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ABSTRACT
Campylobacter jejuni is a prevalent infectious enteritis mainly foodborne from chickens.
Despite of reducing C. jejuni food contamination dramatically decreases the occurrence
of campylobacteriosis, few effective approaches are available for the bacterial reduction
in chickens. The aim of this study was to use microbial metabolic product deoxycholic
acid (DCA) to reduce C. jejuni chicken colonization. Broiler chicks were fed 0 or 1.5
g/kg DCA, lithocholic acid (LCA), or urodeoxycholic acid (UDCA) in diets or orally
gavaged with cholic acid (CA, 1.5g/kg body weight). Birds were also transplanted with
DCA modulated anaerobes (DCA-Anaero) or aerobes (DCA-Aero). Birds were infected
with 109 CFU/bird human clinical isolate C. jejuni 81-176 or chicken isolate C. jejuni
AR101 and were weighed or sacrificed to enumerate cecal C. jejuni colonization levels.
C. jejuni was culture in broth with various concentrations of DCA, CA, and taurocholic
acid (TCA). DCA modulated microbiota were analysis by real time PCR at phylum level.
Notably, C. jejuni 81-176 was readily colonized intestinal tract at 105 CFU/g cecal
digesta at d16 and reached an almost plateau of 2.8x107 CFU/g cecal digesta at d21.
Remarkably, DCA excluded C. jejuni cecal colonization at 100, 99.997, and 100% at 16,
21, and 28 days of age. DCA also improved chicken growth performance of body weight
gain compared to infected control birds (1.45 vs. 1.29 kg/bird) at d28. Interestingly, DCA
failed to inhibit C. jejuni 81-176 in vitro growth. Neither chicken ages of infection nor
CA, LCA or UDCA altered C. jejuni AR101 chicken colonization level, while DCA
reduced 91% of the bacterium in chickens at d28. Notably, DCA diet induced a distinct
microbiota composition of phyla firmicutes (82.7.1 vs. 98.8%) and bacteroidetes (16.9 vs.
0.8%) compared to infected control birds. Importantly, DCA-Anaero attenuated 93% of

C. jejuni colonization at d28 compared to control infected birds (1.79x106 vs. 2.52x107
CFU/bird). In conclusion, DCA shapes microbiota composition against C. jejuni
colonization in chickens, suggesting a bidirectional interaction between microbiota and
microbial metabolites. Simultaneously reconstituting both microbiota and microbial
metabolites may render better therapeutic effect against enteritis or pathogen
colonization.
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CHAPTER I

LITERATURE REVIEW
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1.1

Introduction

Food-production animals are critical food sources to humans because animal products
contain valuable and balanced protein as well as many other essential micronutrients such
as iron, zinc, and vitamins B-12 and A (WHO, 2003). The fast growing population along
with the urbanization has increased the consumption of animal products (Broglia and
Kapel, 2011). It has been estimated that the consumption of animal products will be
increased to 376 million tons per year by 2030 due to rising human population and
globalization (Dhama et al., 2013). Broiler chicken meat is more cost effective than beef
because the cost of one kg of red beef meat is three to four times the cost of broiler meat
(Wahyono and Utami, 2018). Unfortunately, animal products often carry zoonotic
pathogens that can reach humans and cause foodborne diseases. Foodborne pathogens
include various bacteria such as Salmonella Typhimurium, Campylobacter jejuni,
Escherichia

coli,

Listeria

monocytogenes,

Yersinia

enterocolitica,

Clostridium

perfringens, helminths such as Taenia solium and protozoa such Toxoplasma gondii and
Cryptosporidium parvum (Dhama et al., 2013). Despite various food safety strategies, 47.8
million foodborne sickness cases in the United States were recorded in 2013 which
included 127,839 hospitalizations and 3,037 mortalities (Scallan et al., 2013).
Campylobacter jejuni (C. jejuni) is one of the most common causes of human
gastrointestinal illnesses in the development countries (Bronzwaer et al., 2009).
Campylobacteriosis is mainly caused by poor preparation of chicken meat or consumption
of contaminated meat (Tam et al., 2009). Many surveys revealed that the bacterial loads of
Campylobacter were high in the retail chicken meat. For instance, one survey in
Washington D.C. found that more than 70% of broiler meat samples contained
2

Campylobacter (Zhao et al., 2001).

It was estimated that there are one million

campylobacteroisis cases occur in the United States every year (Scallan et al., 2011), which
cause the economic loss of $1.7 billion (Batz et al., 2012).

1.2
1.2.1

Campylobacter jejuni
History of Campylobacter jejuni

Theodor Escherish was the first scientist who acknowledged the presence of
Campylobacter with a spiral shaped bacteria in stool samples of neonates with diarrhoea
in 1886 (Escherich, 1886; Samie et al., 2007; Skirrow and Butzler, 2000). Two British
veterinary surgeons reported several novel “Vibrio” species in a range of animals in 1906
and a new bacterial specie Vibrio foetus ovid was isolated from aborted lamb foetuses and
their dams as early as 1909 (McFadyean and Stockman, 1909). A bovine strain of Vibrio
spp. was isolated in 1938 from a milk-borne disease affecting humans and causing an
outbreak in the USA (Levy, 1946). In 1947, Vincent isolated this organism (Vincent,
1947). Consequently in the USA, Vibrio spp. were isolated from 11 different patients who
had gastroenteritis (King, 1957). Among the 11 isolates, seven strains were V. fetus, and
the other four were closely related species, titled ‘related vibrios’. Based on carbohydrate
fermentation and DNA guanine-cytosine (GC) content, King reported that “related vibrios”
groups were differentiated into two groups of Vibrio spp. (Sebald and Veron, 1963). The
“related vibrios” group bacteria have less GC content and were assigned to a new genus
Campylobacter indicating its ‘curved rods’ morphology. Since then, the knowledge on
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Campylobacter has expanded and many Campylobacter genomes are now available in
GenBank.
Campylobacter genus contains 29 species and 12 subspecies and belongs to
proteobacteria, which also comprises Helicobacter, Arcobacter and Wolinella (On, 2001;
Pitkänen and Hänninen, 2017). The Campylobacter genus included a group of closely
related organisms including C. upsaliensis, C. helviticus, C. jejuni, C. coli, C. lari, and C.
curvisus and most of them are known to colonize the gastrointestinal tracts of a variety of
host species (Wassenaar and Newell, 2000). Wasssenaar and colleague also
acknowledged that C. jejuni and C. coli of the Campylobacter spp. are the most important
zoonotic human’s enteric pathogens in industrialised countries. C. jejuni is the major
pathogen of campylobacteriosis and is responsible for 95% of cases, whereas C. coli
accounts for only 5% (Pitkänen and Hänninen, 2017). Clinical manifestations caused by
different Campylobacter spp. are very similar (Gillespie et al., 2002). Various
epidemiological studies have treated campylobacteriosis caused by different
Campylobacter spp. as a single clinical entity because of lack of differential diagnostic
tools (Siemer et al., 2005).

1.2.2

Morphology and biochemical characteristics

Campylobacter spp. are gram-negative curved rods, motile, non-spore forming bacteria
(Lee and Newell, 2006). The size of Campylobacter spp. members ranged from 0.2 to 0.8
µm wide and 0.5 to 5.0 µm long and dividing cells attaching together often show spiral
forms (Hansson, 2007). C. jejuni is highly motile bacterium due to the presence of a
4

flagellum at one end or both ends of the cell. The motility is characterised by rotating
movement to rapid corkscrew-like motion, which requires use of their unipolar or bipolar
flagella (Konkel, 2001). The bacterium is highly adaptive to the bird intestine, reflected
by their adaptation to grow at varied temperature range of 30-44°C but an optimum
growth is seen at of 42°C (Nielsen, 2010). C. jejuni requires oxygen concentration in a
range of 3 to 15% and 3-5% carbon dioxide and so it is microaerophilic. Having
relatively small genomes (1.6 – 2.0 megabases), C. jejuni establishes long term
associations with their hosts and biochemically the bacterium is catalase and oxidase
positive and urease negative (Parkhill et al., 2000). C. jejuni hydrolyses hippurate, but C.
jejuni subsp. doylei varies in its capability to hydrolyse hippurate (Vandamme et al.,
1992), hence various other additional biochemical tests are used to differentiate
Campylobacter spp.

1.2.3

Virulence factors of Campylobacter jejuni

While some Campylobacter spp. have been studied and fully sequenced, their likely
pathogenicity, host association, population diversity, and epidemiology are still not clear.
When colonizing the intestine, C. jejuni expresses numerous virulence factors and
establishes an infection. Below are emphasised virulence factors which are important for
successful infection and host interaction (Table 1.1).

5

1.2.3.1

C. jejuni flagellin, motility, adherence, and invasion

Motility is important for any organism to establish an active infection. The existence of
flagellin is essential for the bacteria to initiate and expand colonization (Wassenaar et al.,
1993; Nachamkin et al., 1993). C. jejuni infiltrate the mucus barrier of host intestine by
its polar flagella at one or both ends which form cork-screw movement and allow them to
enter into mucus (Szymanski et at., 1995). The flagellum has two sub units flaA and flaB
endangered to antigenic variation and phase variation (Guerry et al., 1991). Apart from
these two proteins several other proteins are also involved in flagellar expression
(Parkhill et al., 2000).
Adhesion to the host cells is the first step for pathogens successfully infecting the host,
followed by colonization and invasion (Pizarro-Cerda et al., 2006). CadF on C. jejuni is an
important adhesion molecule. CadF mediates adherence in C. jejuni by binding to
fibronectin on the intestinal epithelial cells, and facilitates the bacterial colonization in
chickens (Konkel et al., 1997). Another essential C. jejuni adherence molecule is JlpA
which adheres with heat shock protein on epithelial cells (Jin et al., 2003).
Once C. jejuni is able to infiltrate the barrier and have entered into the mucus layer, it
requires to adhere to the surface for long term foundation and invasion. Biopsies studies
of early C. jejuni invasion into intestine showed that the bacterium has the ability to invade
gut tissue cells (Van Spreeuwel et al., 1985; Oelschlaeger et al., 1993).
The bacteria enter through interrupted tight junctions of epithelial cells (Grant et al.,
1993; Bras et al., 1999). Here either it can reinvade the epithelial cell, replicate and
induce apoptosis or be phagocytised by macrophages (Kiehlbauch et al., 1985). If C.
jejuni is able to reinvade into intestinal epithelial cells, it exists within a membrane bound
6

compartment. Over the time of its residence, it acquires a metabolic state which renders
an uncultivable status of this bacterium (Kiehlbauch et al., 1985; Humphrey et al., 1986;
Russell et al., 1994). This state will possibly be intermittent by a conditions of oxygen
limitation, and indicate that C. jejuni becomes oxygen sensitive or alters its respiration
mode inside the epithelial cells (Watson and Galan, 2008).

1.2.3.2

Biofilm formation and quorum sensing

Biofilms are defined as multicellular layers of bacteria embedded within a matrix of
extracellular polymeric substances to persist in unfavourable environment (Donlan and
Costerton, 2002). Among the strategies to resist, biofilm is a life-style known to protect
bacteria from various environmental stresses, antimicrobial agents and also increased
bacterial resistance to host immune response ( Donlan and Costerton, 2002; Chmielewski
and Frank, 2003). Inside the biofilm, bacteria is protected from disinfectants and
antimicrobials and become more resistant compared to their planktonic counterparts (Fux
et al., 2005). The formation of biofilm may significantly increase the survive ability of
bacteria to unfavourable environment, such as the formation of biofilm by C. jejuni in
response to oxygen exposure (Murphy et al., 2006). C. jejuni strains have been reported
to form different types of biofilm characterized as a structure attached to a surface, a
pellicle formed at the surface of the liquid, or aggregates floating in the liquid culture
(Joshua et al., 2006). Quorum sensing (QS), a cell-to-cell communication system helps in
various C. jejuni virulence factors such as biofilm formation regulation (Reeser et al.,
2007), autoagglutination (Jeon et al., 2003; Guerry et al., 2006), swarming motility (Jeon
et al., 2003), transcription of cytolethal discending toxin (CDT) (Snelling et al., 2005),
7

and colonization of chickens and sensitivity to hydrogen peroxide (Quinones et al.,
2009).

1.2.3.3

Cytolethal distending toxin and haemolysin

C. jejuni secretes cytolethal distending toxin (CDT) which is a protein with subunits of
CdtA, CdtB and CdtC. These three units together block cell division by arresting G2-phase
cell cycle (Lara-Tejero and Galan, 2001). Two units of CdtA and CdtC bind to the cell
surface and facilitate the delivery of the active subunit CdtB. CdtB uses its DNase-I-like
activity to cleave dsDNA molecules at G1 and G2 stage (Whitehouse, 1998). The toxin
also provides the bacterium an evasion from host immune response. In addition, a few
studies have reported C. jejuni haemolytic activity (Arimi et al., 1990) by which the
bacterium is able to haemolysed the red blood cell membrane, and liberated heme is used
as iron source (Reid et al., 2008). C. jejuni has two genes associated with haemolytic
activity including ceuE and pldA. CeuE functions as a periplasmic binding protein and is a
part of an ABC transport system. pldA is a gene encoding an outer membrane
phospholipase A protein and has been studied in C. coli, and found its contribution in cellassociated haemolysis (Grant et al., 1997).

1.3
1.3.1

Campylobacteriosis
Campylobacteriosis in humans

C. jejuni is the major cause of campylobacteriosis in human, followed by C. coli,
C.upsaliensis, C. lari and C. fetus (Acheson and Allos, 2001). Consumption of
undercooked chicken meat or contaminated food is the main sources of campylobacteriosis
8

disease in humans (Skirrow and Benjamin, 1980a; Skirrow and Benjamin, 1980b). Both
tamed (Blaser et al., 1980) and wild animals (Kapperud and Rosef, 1983) are work as
reservoirs for the bacteria. The other modes of transmission comprise of contacting with
faecal material, exposing from animals (specifically ruminants), or entertaining swimming
(Mullner et al., 2009). In addition, contaminated water (Richardson et al., 2007), milk
(Robinson and Tones, 1981), seafood (frost, 2001), vegetables, and fruits (Pielaat et al.,
2014) are considered to be vehicles of the bacteria to humans and other animals. A dose as
few as 800 colony forming unit (CFU) is able to induce the illness in humans (Black et al.,
1988). Other studies were able to report the illness with 360 CFU (Hara-Kudo and Takatori,
2011). It’s very important and critical to understand the comparative influence of each
transmission pathway to decide a protective and effective control measurement.

1.3.2

Campylobacteriosis clinical symptoms and complications

The incubation period ranges from 2-5 days, but has been reported up to 10 days
(Butzler, 2004). In human, manifestations are varied including acute gastroenteritis,
cramping, abdominal pain, fever, and more or less, vomiting and headaches (Snelling et
al., 2005). Campylobacteriosis is usually a self-limiting disease and the patients may
recover with no medical intervention (Rosenquist et al., 2003). However, some patients
may develop several complications. Guillain-Barre Syndrome (GBS) is common in postinfectious complications and causes flaccid paralysis affecting peripheral and cranial
nerves in severe cases (Pithadia and Kakadia, 2010). Miller Fisher syndrome is variant of
GBS, causes a non-paralytic condition with inability to move the eyes and nonreactive
pupils (Fisher, 1956). Reactive arthritis is also noted in association with C. jejuni post9

infection (Nielsen, 2010). In addition, Campylobacter spp. have been related to other
gastrointestinal manifestations such as inflammatory bowel diseases (IBD), Barrett's
esophagus, and colorectal cancer, and in rare case extragastrointestinal manifestations
such as bacteremia, lung infections, brain abscesses, and meningitis (Man, 2011).
1.3.3

Risk factors for campylobacteriosis

Although consumption of contaminated poultry products and other foods is the major
source of campylobacteriosis, other risk factors contribute to the infection. Traveling is
an important risk factor. In the United States, international travel was responsible of 18%
of Campylobacter infections between 2005 and 2011 (Ricotta et al., 2014), and domestic
travel in the USA increased the incidence of the infection in 2008 (OR: 2.5; 95%CI= 1.4–
4.6) (Denno et al., 2009).
Other pathogen infections often lead to the susceptibility to campylobacteriosis in
humans. In developing countries, Campylobacter infection is frequently associated with
other enteric pathogens infection such as E. coli and Rotavirus, but it was rare in
developed countries (Coker et al., 2002). HIV patients are highly susceptible and show
severe illness comparing with non-HIV patients (Tee and Mijch, 1998). Living in rural
areas where farm animal density is high increase the incidence of the disease (Arsenault
et al., 2012).
In addition, studies found that sex and age are associated with Campylobacter infection in
humans. By using FoodNet data on Campylobacteriosis infection incidence in the United
States between 1996 and 1999, Samuel et al. (2004) found that campylobacteriosis was
higher in males of all ages. In Canada, Green et al. (2006) found the highest rate of
Campylobacter infection to be among 0–4 years old and 20–39 years old, with slightly
10

higher rates occurring in males (Green, 2006). However, the reason behind such high
incidence in males compared to females is not fully understood (Friedman, 2000). In
Germany, the study conducted by Fitzenberger et al. (2010) corroborates this pattern:
campylobacteriosis incidence being highest among those under five years of age (61
cases/100,000), and those aged 15–44 years (56 cases/100,000) (Fitzenberger, 2010).
Fernandez et al. 2008 found that children suffering from malnutrition were more frequent
carriers of Campylobacter spp. (31.4%) than normal children (9.9%) in Chile.

1.3.4

Treatment and antibiotic therapy

Although in normal illness most of campylobacteriosis related diarrheal infection are
self-limiting, certain cases require antibiotic treatment such as erythromycin (macrolide
antibiotic) or ciprofloxacin (fluoroquinolones) (Balfour and Faulds, 1993). Multidrugresistant (MDR) Campylobacter in humans (Kaakoush et al., 2015) as well as in
domesticated animals (Qin et al., 2011) has raised concerns about the usage of antibiotics.
In recent years, a number of studies report the increasing number of patients infected with
strains resistant to erythromycin and ciprofloxacin (Engberg et al., 2001), and such
individuals may have worse clinical outcomes (Helms et al., 2006) such as Guillain-Barre
Syndrome (GBS), Miller Fisher syndrome, intestinal haemorrhage (Chamovitz et al.,
1983), toxic megacolon (McKinley and Carlton, 1980). Recently, a few studies have been
conducted to prevent and treat camylobacteriosis using antibiotics alternative. mTOR
pharmacological inhibitor is able to prevent and treat campylobacteriosis in mice (Sun et
al., 2012). Microbial metabolic product deoxycholic acid prevents and treat C. jejuniinduced colitis in mice (Sun et al., 2018).
11

1.4
1.4.1

Preventing C. jejuni colonization in chickens
C. jejuni colonization in chickens

Poultry has been concluded as the main source of infection (Friedman et al., 2000). In
2002, surveys in the United States and in the United Kingdom, 68%–83% of broiler
carcasses contained the bacteria (Jorgensen et al., 2002). Cattles, chickens, and sheep carry
the C. jejuni bacteria as asymptomatic carriers (Newell and Fearnley, 2003; Devane et al.,
2005), where pigs and sheep have been identified as reservoirs of C. coli (Parsons et al.,
2010; Nesbakken et al., 2003).
Chickens are considered as the natural host of C. jejuni (Yogasundram et al., 1989). Stern
and colleagues in their one year survey study reported that approximately 90% of the flocks
were positive to C. jejuni in the United States (Stern et al., 2001). In the UK, another survey
during 2014 to 2015 showed that more than 72.5% of the broiler chicken carcasses at the
retail stores were contaminated with C. jejuni (FSA, 2014). In Italy, a survey reported that
60% of the broiler chickens were carrying the pathogen (Comin et al., 2014). During 2009,
76% of broiler chickens meat carried Campylobacter at the retail stores in France (GuyardNicodème et al., 2015). This high load on broiler meat is due to the fact that C. jejuni
bacteria spread rapidly between the birds (Newell and Fearnley, 2003), and the infected
birds show no signs of illnesses (Lee and Newell, 2006). In addition, cross contamination
between the negative and positive flocks can occur at the processing level and leads to
increase the spreading the bacterium (Skirrow, 1990)
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C. jejuni is ubiquitous at the area surrounding the farms (Newell and Fearnley, 2003). Most
broiler flocks become infected with C. jejuni at 2 to 3 weeks of age (Evans and Sayers,
2000). Ringoir and colleagues proposed that the susceptibility to the pathogen in 2 day old
chicks was higher than 2 weeks old chicks (Ringoir et al., 2007). In agreement with this,
Cawthraw and Newell found that 1 day old broiler chicks were more susceptible to the
pathogen in comparing with 1 week old chicks (Cawthraw and Newell, 2010). Horizontal
transmission of the bacteria between the birds occurred in a very fast manner, and the
majority of birds in the same flock become positive within days (Shreeve et al., 2000).
Once the infection occurs, C. jejuni is able to proliferate in a high rate and reaches levels
as high as 109 CFU in the ceca (Wassenaar et al., 1993). Beside the cecum, C. jejuni
colonizes the mucus layer of the small intestine, and can reach to the liver and the spleen
of the infected birds (Newell and Fearnley, 2003).
Infected birds shed the bacteria in feces and contaminate the surrounding area such as the
litter, feed and water (Newell and Fearnley, 2003). Worker activities at the farm, rodents,
flies, and other farm and wild animals are important vectors of the bacteria (Newell and
Fearnley, 2003), since infected birds can shed high numbers of the bacteria and
contaminate the soil, water sources, dust, building surfaces, and the air that surrounds the
farm area (Kaakoush et al., 2015). C. jejuni can survive up to 6 days in chicken feces which
can contaminate the environment when used as fertilizer (Ahmed et al., 2013).
It appears that the incidence of the infection in free-range chickens is significantly higher
than the intensively raised chickens, and can reach as high as 100% of the flock (Heuer et
al., 2001). Heuer and colleagues suggested that the abundance of the pathogen in the
13

environment which causes more exposure to the chickens is the reason of the higher
positivity of such chickens. One study found that the prevalence of Campylobacter species
in organic broilers chickens is three times higher than in conventionally raised broilers
(54.2% versus 19.7%) (Rosenquist et al., 2013).
The ability of Campylobacter-positive lying hens to pass C. jejuni to their offspring
through eggs is still controversial (Newell and Fearnley, 2003). The late infection ages of
chicks supports the fact that broiler chicks gain C. jejuni from the environment rather than
parent flocks, comparing with vertical transmission in Salmonella spp., in which chicks
become infected at day one of age (Newell and Fearnley, 2003). Studies have been able to
isolate C. jejuni from both male (Cox et al., 2001) and female reproductive systems
(Camarda et al., 2000). In addition, other studied were able to infect chicken eggs with C.
jejuni. For instance, in one study, the eggs were exposed to a suspension contained C.
jejuni. The results showed that 4% of the eggs were infected, indicating the possibility of
transmitting the bacteria to the eggs from feces (Allen and Griffiths, 2001). Nonetheless,
C. jejuni remains in the egg shells and do not contaminate the inner contents of the eggs
(Niell et al., 1985). No study have found strong evidence for the vertical transmission of
the bacteria (Petersen et al., 2001; Sahin et al., 2003; Callicott et al., 2006). More research
need to be conducted to strongly prove whether the vertical transmission is possible or not.
Furthermore, poultry is also an important reservoir of other Campylobacter species, such
as C. upsaliensis, and C. concisus (Kaakoush et al., 2014), as well as C. lari (Hariharan et
al., 2009).
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1.4.2

Preventions of C. jejuni chicken colonization by biosecurity, bacteriophage,
vaccination, and probiotics

Controlling Campylobacter in poultry represents an immense challenge to the agriculture
and food industries (Newell et al., 2010) as these bacteria are well adapted to avian species
such that they may be considered commensal organisms of poultry. Following are some of
current prevention approaches.
Bacteriocins are toxic peptides produced by certain bacteria and are able to kill or prevent
the growth of other bacteria (Cotter et al., 2013). Administration of bacteriocin-producing
bacterium Paenibacillus polymyxa or bacteriocins to chickens infected with 108 CFU/bird
of four different strains of C. jejuni (AL-22, BH-6, Bl-1, CL-11) at day one of age, reduces
the bacterial colonization from 104.6 -106.3 CFU to an undetectable limit at day 10 of age
(Stern et al., 2005). However, peptide bacteriocins can be degraded by the host digestive
system (Joerger, 2003) and it remains elusive how it evades intestinal digestion and
prevents C. jejuni colonization. The development of bacterial resistance to bacteriocins is
another concern for applying it to reduce C. jejuni chicken colonization (El-Shibiny et al.,
2009).
Since farm workers are important vehicles for the bacterium dissemination, applying
hygienic standards such as washing hands, using shoes covers, dipping the feet in
disinfectant solutions before and after dealing with chickens have showed to reduce cross
contamination between chickens (Newell et al., 2011). Applying chemicals such as organic
acids, acidified sodium chlorite, trisodium phosphate, or UV light during primary
processing, freezing or irradiating at the slaughterhouses has showed reduction in
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Campylobacter numbers on chicken carcasses (Wensley and Coole, 2013). Its high cost
and negative effects on the meat quality have reduced its applications (Saxena et al., 2013).
Bacteriophages are bacterial viruses that have been used to control infectious bacteria such
as Shigella dysenteriae since 1919 (Chanishvili, 2012). Bacteriophages have also been
studied for use in the biocontrol method of Campylobacter species. Bacteriophage therapy
was able to reduce Campylobacter counts by approximately 2 log10 cfu/g in a study in
2010 (Carvalho et al., 2010). However, in two of three field trials, a phage cocktail of log10
5.8-7.5 pfu/bird applied to birds of 31 to 36 days old fails to reduce Campylobacter spp.
colonization at 42 days of age (Kittler et al., 2013). Even though these results are
promising, Campylobacter quickly develops resistance against the bacteriophages and is
able to grow and reach the same pretreatment numbers (Hermans et al., 2011).
Vaccination is the administration of a killed or attenuated pathogen or parts of it to
trigger the host immune system. Many efforts have been done to develop effective
vaccines against C. jejuni, such as flagellar proteins vaccine, attenuated C. jejuni vaccine,
and killed C. jejuni, however, no vaccine has successfully prevented the bacteria from
colonizing the chicken gut (Kaakoush et al., 2015). In a study, birds vaccinated with C.
jejuni 81–176 nanoparticle-encapsulated outer membrane proteins at d 7 and 21 and
challenged with 1 × 108 cfu C. jejuni 81–176 at 35 days of age were resistant to the
infection (Annamalai et al., 2013). C. jejuni cecal counts in the vaccinated birds stay
below the detection limit at 42 days of age in the groups that received the vaccine
compared to 106 CFU/g feces in control birds. More research is needed in this field in
order to develop an effective chicken vaccine against C. jejuni.
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1.4.3

Preventions of C. jejuni chicken colonization by microbiota

The microbiota defines as the commensal, symbiotic and pathogenic microorganisms that
colonize the gastrointestinal tract and other areas of human and animal bodies (Sender et
al., 2016). Once hatched, the chicks acquire microbiota from the environment at the
hatchery (Pedroso et al., 2005). Studies have showed that chicken embryos gain microbiota
even before the hatching phase either directly from the oviducts of their mothers (Gantois
et al., 2009) or indirectly from the environment through the pores in the eggshells (Roto et
al., 2016). Comprehensive dataset analysis showed that 915 operational taxonomic units
(OTUs) were presented in broiler gut (Wei and Morrison, 2013). They showed that thirteen
phyla are present including Firmicutes (70%), Bacteroidetes (12.3%) and Proteobacteria
(9.3%), which accounting for more than 90% of all the sequences. The other phyla are
Actinobacteria, Cyanobacteria, Spirochaetes, Synergisteles, Fusobacteria, Tenericutes, and
Verrucomicrobia. Additionally, 117 genera were described, mostly Ethanoligenes,
Clostridium, Ruminococcus, Lactobacillus, Desulfohalobium and Bifidobacteriu.
Gut microbiota is important to the digestive system function, host metabolism, and host
immune function (Ballou et al., 2016). Gut microbiota is also able to digest complex
indigestible carbohydrates such as polysaccharides, oligosaccharides, and disaccharides
and converts them to simple to sugars, which can be further fermented to short chain fatty
acids (SCFAs), mainly acetate, propionate, and butyrate (Pan and Yu, 2014). Chicken gut
microbiota contributes crucial nutrients to the host such as ammonium, amino acids, and
some vitamins (Pan and Yu, 2014). Chambers and Gong found that SCFAs increase the
development and growth of enterocytes, which leads to bigger intestines and ceca in
conventional broilers compared to germ-free boiler chickens (Chambers and Gong, 2011).
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Competitive exclusion is an important strategy of the intestinal microbiota against
intestinal pathogens (Gabriel et al., 2006). Attachment of the pathogens to the epithelial
layer of the intestine is the first step of the pathogens in birds (Lan et al., 2005). The
intestinal mucosa in healthy birds is covered by a layer of microbiota that can effectively
block the attachment sites and competing with pathogens (Lawley and Walker, 2013).
Microbiota are also able to produce substances that inhibit the growth of some pathogens,
such as hydrogen peroxide (H2O2), diacetyl, bacteriocins and organic acids (Clavijo and
Flórez, 2017). Organic acids such as lactic, acetic, or propionic acid, increase the acidity
in the intestine and decrease the proliferation of the pathogenic bacteria (Blajman et
al., 2015).
Nurmi and Rantala in 1973 first highlighted the relationship between susceptibility to
Salmonella infection and the late development of the gut microbiota in chickens. Research
have been actively conducted to they are effective in controlling salmonella and C. jejuni
infection in chickens using chicken origin microbiota, the administration of microbiota
failed to reach the same results in C. jejuni colonization in chickens (Mead, 2000). C. jejuni
colonization influences cecal microbiota with reductions in the relative abundance of
family Lactobacillaceae and the Clostridium cluster XIVa (Connerton et al., 2018).
Microbiota metabolites Short-Chain Fatty Acids (SCFAs) are sensed by C. jejuni for
discriminating different spatial areas of intestines to colonize ceca of chickens (Luethy et
al., 2017). Interestingly, probiotics Bifidobacterium longum PCB133 and a xylooligosaccharide failed to reduce C. jejuni chicken colonization using plate enumeration
(Baffoni et al., 2017).

18

1.4.4

Microbial metabolic product bile acids

Bile acids with steroidal structure are synthesized from cholesterol in the liver and secreted
into the bile with cholesterol, phospholipids and bilirubin. Bile acids are biosynthesized by
hepatocytes and secreted into the bile canaliculi and subsequently in the gall bladder
(Thomas et al., 2008). The biosynthesize of primary bile acids in the liver can be
accomplished by two different pathways. The main pathway, which is responsible for the
production of up to 75% of the bile acids, is known as the classical or neutral pathway,
where the cholesterol undergoes 7α-hydroxylation process in the presence of 7-αhydroxylase (CYP7A1) (Thomas et al., 2008). The other pathway is called the alternative
or acidic pathway which is catalyzed by the enzyme sterol-27-hydroxylase (CYP27A1)
(Russell, 2003). The primary bile acids are cholic acid (CA) and chenodeoxycholic acid
(CDCA) which are typically conjugated to glycine or taurine before secretion (Hofmann et
al., 2010). In response to host meal, biles flow out of liver in the gall bladder, and are
released into the upper intestine (Oelkers et al., 1997). In the host intestine, bile acids work
as detergents which emulsify fats, and assist in digestion, absorption and excretion. In
addition to the digestion function, there are other roles of bile acids in the host that have
been recognized, in particular via their role as endogenous ligands for cell receptors such
as the nuclear receptor farnesoid X receptor (FXR), and the G protein-coupled plasma
membrane bile acid receptor TGR5 (Jia et al., 2018). Bile acids themselves act as signalling
molecules and regulate their own synthesis, and control the synthesis of cholesterol in the
body (Lu et al., 2000). As FXR and TGR5 agonists, bile acids participate in some
physiological processes in the host including the modulation of lipid, glucose and energy
homeostasis, and the regulation of their synthesis, conjugation and transport (Mullish et
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al., 2018). After their function in digestion, more than 95 % of bile acids are reabsorbed
and sent back to the liver via portal circulation (Pellicoro et al., 2007). The primary bile
acids CA and CDA are regularly transformed to the secondary bile acids (deoxycholic acid
and lithocholic acid, respectively) by colonic bacteria (Nagengast et al., 1995)
(Figure 1.1).

1.4.5

Bile Acids and microbiota interaction

The intestinal microbiota is composed of several thousands of species, which together
maintain host gut physiology and homeostasis (Tremaroli and Bakhed, 2012). The
composition of the gut microbiota is affected by bile acids (Kakiyama et al., 2013). Bile
acids cause disruption of the bacterial cell membranes, damaging the DNA and alteration
in the protein conformation within the bacteria (Urdaneta and Casadesus, 2017). Due to the
detergent activity of the biles, and the lipophilic nature of bacterial membranes, they
represent one of the main targets of bile (Kurdi et al., 2006). Furthermore, bile acids are
able to chelate with some essential ions of the gut microbiota such as iron and form Fe2+–
bile salt complexes (Symeonidis and Marangos, 2012). Complex and significant changes
in the gut microbiome are observed when rats are fed bile acids (Islam et al., 2011). For
example, Islam and colleague added 1.25 mmol/kg and 5 mmol/kg of CA into rat diet. CA
diet increased rat gut phylum Firmicutes between 93-98% compared to 54% in control rats
while Bacteroidetes and Actinobacteria in CA rat decreased (Islam et al., 2011). Studies
have demonstrated that alteration in gut microbiota or “dysbiosis” by too much bile acids
have been associated with chronic liver disease and cirrhosis (Ridlon et al., 2013). Cirrhosis
patients show reduced levels of bile acids as well as alteration of the gut microbiome, often
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associated with decreased abundance of 7α-dehydroxylating Gram-positives like
Lachnospiraceae, Ruminococcaceae, and Blautia in feces (Kakiyama et al., 2013).
Bile acids are biotranformed or metabolized by gut microbiota. Briefly, the first stage of
bile acid modification by the gut microbiota is from the enzymes named bile salt hydrolases
(BSHs) (Mullish et al., 2018). These enzymes deconjugate the taurine or glycine groups
from conjugated bile acids via a hydrolysis reaction, and therefore form the primary bile
acids CA and CDCA (Mullish et al., 2018). The second enzymatic steps are the removal
of the hydroxyl group of C-7 from the primary bile acids and convert them into secondary
bile acids in a process called 7-α-dehydroxylation (Mullish et al., 2018).
In order for the gut microbiota to survive in such harmful effect of BAs, they have
developed several resistance mechanisms. The enterobacterial common antigen (ECA),
which is a family-specific glycolipid present in the outer layer of Salmonella enterica
membrane, is an example of such adaptation. It is found that a mutant Salmonella enterica
with an ECA synthesis gene is more sensitive to bile acids (Ramos-Morales et al., 2003).
When bile acids insert into the cytoplasm of the bacteria, another adaptation mechanisms
takes place by the active extrusion of the bile acids by efflux pumps (Piddock, 2006). The
efflux system AcrAB–TolC is the best characterized mong the efflux systems in
enterobacterial spp. (Nikaido et al., 2008). In addition, Begley et al found that the
deconjugation process of the bile acids that occur in the presence of BSH in wild type
Lactobacillus amylovorus and Lactobacillus plantarum made them more tolerant to the
bile acids in comparison with mutant BSH of the same bacteria (Begley et al., 2005). The
presence of bile triggers the expression of virulence gene expression in several pathogenic
bacteria that infect the digestive tract (Sistrunk et al., 2016). For instance, primary bile
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acids promote the germination in the spore-forming bacteria Clostridium difficile (Sorg and
Sonenshein, 2010). In Escherichia coli, one example of bile resistant is the efflux pump
mechanisms, such as AcrAB-TolC (Sengupta et al., 2014). In C. jejuni, the bile salts trigger
the expression of the CmeABC efflux pump (consists of a single periplasmic protein
(CmeA), an inner membrane transporter (CmeB), and a single outer membrane protein
(CmeC)), and leads to increase the tolerance of the bacteria against bile acids (Lin et al.,
2003). According to Lin et al, mutant CmeABC C. jejuni bacteria were unable to colonize
chicken intestine (Lin et al., 2003).

1.4.6

Bile Acids on health and diseases

Beside their known digestive function as emulsifier to lipids, more attention has been raised
about bile acids function as signalling molecules in the body which may lead to develop
drugs for chronic diseases such as obesity, diabetes and atherosclerosis. (Thomas et al.,
2008). In addition, bile acids are prescribed to patients suffer from deficiency in bile acids
production (Hofmann, 1999). FDA approved deoxycholic acid for the treatment of
submental fat to reduce facial fullness or convexity through disrupting adipocytes
(Sykes et al., 2017). Another example is the usage of urodeoxycholic acid to treat
patients with congenital abnormal bile acids (Hofmann, 1999), patients with primary
biliary cirrhosis (Pares et al., 2006), and gallstone (Montini et al., 1994).
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APPENDIX
Table 1.1

Virulence genes of C. jejuni

Adhesin

In vitro cell line

CadF
FlpA
CapA
JlpA
PEB1
PEB4 (surA)
Cj1496c
MOMP

Int407
Int407
Caco-2
HEp-2
HeLa
Int407
Int407
Int407

Important for

Reference
Monteville et al., 2003; Konkel et al.,
1997
Konkel et al., 2010
Ashgar et al., 2007
Jin et al., 2001, Flanagan et al., 2009
Kervella et al., 1993
Asakura et al., 2007
Kakuda and DiRita, 2006
Moser et al., 1997

chicken
chicken
chicken
chicken
mouse
mouse
chicken
chicken
chicken;
CPS
Int407, Caco2
Mouse
Bacon et al., 2001, Jones et al., 2004
LOS
Int407
chicken
Fry et al., 2000, Müller et al., 2007,
CadF: Campylobacter adhesion to fibronectin, FlpA: fibronectin-like protein A, CapA:
Campylobacter
adhesion protein A, JlpA: jejuni lipoprotein A, PEB1 and 4: protein Pei, Ellison and Blaser 1 and
4,
MOMP: Major outer membrane protein, CPS: Capsular polysaccharide, LOS:
Lipooligosaccharide, ND:
Not determined
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Figure 1.1

Flow chart demonstrates the structures of primary and secondary bile acids
with their synthetic pathways.
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CHAPTER II

MICROBIAL METABOLITE DEOXYCHOLIC ACID SHAPES MICROBIOTA
AGAINST CAMPYLOBACTER JEJUNI CHICKEN COLONIZATION
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2.1

Abstract

Campylobacter jejuni is a prevalent infectious enteritis mainly foodborne from chickens.
Despite of reducing C. jejuni food contamination dramatically decreases the occurrence
of campylobacteriosis, few effective approaches are available for the bacterial reduction
in chickens. The aim of this study was to use microbial metabolic product deoxycholic
acid (DCA) to reduce C. jejuni chicken colonization. Broiler chicks were fed 0 or 1.5
g/kg DCA, lithocholic acid (LCA), or urodeoxycholic acid (UDCA) in diets or orally
gavaged with cholic acid (CA, 1.5g/kg body weight). Birds were also transplanted with
DCA modulated anaerobes (DCA-Anaero) or aerobes (DCA-Aero). Birds were infected
with 109 CFU/bird human clinical isolate C. jejuni 81-176 or chicken isolate C. jejuni
AR101 and were weighed or sacrificed to enumerate cecal C. jejuni colonization levels.
C. jejuni was culture in broth with various concentrations of DCA, CA, and taurocholic
acid (TCA). DCA modulated microbiota were analysis by real time PCR at phylum level.
Notably, C. jejuni 81-176 was readily colonized intestinal tract at 105 CFU/g cecal
digesta at d16 and reached an almost plateau of 2.8x107 CFU/g cecal digesta at d21.
Remarkably, DCA excluded C. jejuni cecal colonization at 100, 99.997, and 100% at 16,
21, and 28 days of age. DCA also improved chicken growth performance of body weight
gain compared to infected control birds (1.45 vs. 1.29 kg/bird) at d28. Interestingly, DCA
failed to inhibit C. jejuni 81-176 in vitro growth. Neither chicken ages of infection nor
CA, LCA or UDCA altered C. jejuni AR101 chicken colonization level, while DCA
reduced 91% of the bacterium in chickens at d28. Notably, DCA diet induced a distinct
microbiota composition of phyla firmicutes (82.7.1 vs. 98.8%) and bacteroidetes (16.9 vs.
0.8%) compared to infected control birds. Importantly, DCA-Anaero attenuated 93% of
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C. jejuni colonization at d28 compared to control infected birds (1.79x106 vs. 2.52x107
CFU/bird). In conclusion, DCA shapes microbiota composition against C. jejuni
colonization in chickens, suggesting a bidirectional interaction between microbiota and
microbial metabolites. Simultaneously reconstituting both microbiota and microbial
metabolites may render better therapeutic effect against enteritis or pathogen
colonization.

46

2.2

Introduction

Campylobacter jejuni asymptomatically colonizes in poultry gut but is one of the
prevalent food borne pathogens in the developed countries. Antibiotic resistant C. jejuni
has been reported in children and adults in the USA and worldwide (1-5). More than 13
campylobacteriosis cases per 100,000 population were recorded in 2014 in the USA,
which represents a 13% increase compared to 2006-2008 and is higher than the combined
incidences by the following 8 bacterial pathogens (6). A total of 1.3 million individuals
are afflicted by the disease, resulting in 76 deaths every year (7). Furthermore, C. jejuni
post infectious complications are important and include arthritis (8), the
neurodegenerative disorder Guillian-Barré Syndrome (9), Irritable Bowel Syndrome (10)
and Inflammatory Bowel Diseases (IBD) (11, 12). Clinical symptoms of
campylobacteriosis include abdominal cramps, watery to bloody diarrhea, fever and
gastrointestinal inflammation (13). At the cellular level, the intestinal tract of C. jejuniinfected patients display infiltration of immune cells such as neutrophils, crypt abscesses
and presence of fecal leukocytes (14).
Although antibiotics treatment has a marginal benefit (1.32 days) on the duration
of symptoms (15), it is the only current available therapy for patients with severe
campylobacteriosis or for those at high risk for severe disease (16). However, increasing
in antimicrobial resistance (17), prompts the need for immediate and sustainable counteractions from agricultural industry to medical field. Antimicrobial resistance presents as
the emergence of multiple drug-resistant microbes or “superbugs”. More recently,
McGann and colleagues reported a “superbug” of an Escherichia coli strain resistant to
the last resort antibiotic, Colistin, in the USA (18). Misuse or overuse of antimicrobial
47

agents in medical and agricultural practice is contributing to exacerbating the episodes of
emerging antimicrobial resistant microbes (17). Hence, an effective and sustainable
solution is to find antimicrobial alternatives in agricultural industry and medical field.
Tremendous efforts have been put forward to prevent campylobacteriosis by
reducing C. jejuni contamination in animal food sources, particularly broiler chicken
meat. The intervention approaches include on-farm biosecurity measures (19), vaccines
(20), probiotics (21), phages (22), and post-slaughter decontamination of poultry
carcasses (23). Reducing carcass Campylobacter counts by 2 log is estimated to decrease
a 30-fold in human campylobacteriosis (24). Although those measures to prevent C.
jejuni contamination have achieved some success, improvement is needed, as evidenced
by the relative consistent rate of campylobacteriosis incidences in the Morbidity and
Mortality Weekly Report at CDC infectious disease database from January, 1996 to June,
2017 (25).
Sparse information is currently available on using microbiota to prevent C. jejuni
colonization in poultry. Microbiota transplantation has shown tremendous success against
recurrent Clostridium difficile infection (26). The production of secondary bile acids by
specific bacteria are attributed to inhibit C. difficile colonization and infection (27). Bile
acids at 3-30 mM in the human small intestine (28), are the byproducts of cholesterol and
biotransformed from conjugated, to unconjugated primary bile acids, and to secondary
bile acids. Majority of bile acids (>95%) are effectively absorbed in intestine (29).
Primary bile acids of cholic acid (CA) and chenodeoxycholic acid (CDCA) are
synthesized from cholesterol in hepatocytes and conjugated with glycine or taurine (30).
In the intestine, the conjugated primary bile acids are deconjugated by bacterial bile salt
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hydrolase (BSH) and further altered by microbiota to produce secondary bile acids
including lithocholic acid (LCA), deoxycholic acid (DCA), and ursodeoxycholic acid
(UDCA). Deconjugating enzyme BSH is present in all major bacterial divisions and
archaeal species in the human gut including members of genus Lactobacillius,
Bifidobacteria, Clostridium, and Bacteroides (29, 31-33). Secondary bile acid producing
bacteria consist of a small population of genus Clostridium, including C. scindens, C.
hiranonis, C. hylemonae (Clostridium cluster XVIa), and C. sordelli (Clostridium cluster
XI) (29). Besides emulsification of lipid for digestion, bile acids are implicated in various
signaling pathways including nuclear receptors of farnesoid X receptor (FXR) (34),
pregnane X receptor (PXR) (35), and vitamin D receptor (VDR) (36), as well as G
protein-coupled receptors of G-protein-coupled bile acid receptor (TGR5) (37) and
sphingosine-1-phosphate receptor 2 (S1P2) (38). The bile acid-metabolizing bacteria such
as Lactobacilli and Bifidobacteria are probiotics and they enhance health by promoting
host immune homeostasis (39). Besides bile acids influence host response, their level is
associated with microbial community dynamics in the gut (40). Bile acids directly inhibit
gut microbes (41) and indirectly modulate microbiota through FXR-induced
antimicrobial peptides (42). Mice fed CA have increased class Clostridia (70 vs. 39%)
compared to control mice, and genus Blautia (including Ruminococcus spp. and
Clostridium cluster XIVa) expands from 8.3 to 55-62% (43). Bile acids, particularly
secondary bile acid DCA, has been reported in association with a variety of chronic
diseases, such as obesity, diabetes, and colorectal tumorigenesis (44, 45). Only very
recently, new evidences shed light on the beneficial property of secondary bile acids in
health and diseases, such as gut motility (46) and C. difficile infection (27). We found
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that specific pathogen free (SPF) Il10-/- mice resisted against C. jejuni 81-176 induced
colitis, while the mice were susceptible to campylobacteriosis after treated with antibiotic
clindamycin which kills bile acid metabolizing bacteria (47). 16S rDNA sequencing,
bioinformatics, and HPLC/MS analysis showed that clindamycin depleted all secondary
bile acids, particularly DCA. Furthermore, anaerobe metabolite DCA prevents and treats
C. jejuni-induced colitis in ex-Germ free mice (47). However, it remains unclear whether
DCA regulates C. jejuni chicken colonization and transmission.
In this study, we hypothesized that DCA prevented C. jejuni chicken colonization. Our
data indicate that DCA indeed prevented against chicken colonization of C. jejuni human
clinical isolate 81-176 or chicken isolate AR101 and even improved growth performance.
Subsequent mechanistic studies found that DCA modulated intestinal microbiota.
Remarkably, DCA-modulated anaerobe attenuated C. jejuni chicken colonization. Thus,
the action of DCA against C. jejuni chicken colonization represents a unique bidirectional
interaction between microbiota and microbial metabolites. It would be more effective
against enteritis or pathogen colonization through modulating both microbiota and
microbial metabolites.

2.3

Material and Methods

Chicken experiment
The experiments were approved by the Institutional Animal Care and Use Committee of
(IACUC) the University of Arkansas. Cohorts of 13 to 18 one-day-old broiler chicks per
group obtained from Cobb-Vantress (Siloam Springs, AR) were neck-tagged and
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randomly assigned to floor pens with a controlled age-appropriate environment. The birds
were fed a corn-soybean meal-based starter diet during 0-10 days of age and a grower
diet during 11-28 days of age. The basal diet was formulated as described before (48).
Bird were fed diet supplemented with 0 or 1.5 g/kg DCA, LCA, or UDCA (all from Alfa
Aesar, MA) from d 0 or gavaged daily with CA (30 mg/kg body weight) from d 4. Birds
were infected with 109 CFU/bird human clinical isolate C. jejuni 81-176 at 14 days of age
or chicken isolate AR101 at d 5, 10, or 14. AR101 was isolated at Poultry Health
Laboratory at University of Arkansas-Fayetteville. Based on our findings, birds were
mostly infected with C. jejuni AR101 at day 10 in order to have enough time for both C.
jejuni colonization and microbiome maturation. Chicken body weight and feed intake
were measured at 0, 14, 21, and 28 of age. Birds were sacrificed at 16, 21 or 28 days of
age to collect cecal samples for enumerating C. jejuni. Cecal digesta samples were
collected for DNA isolation or were ten-fold serially diluted with sterile PBS and
cultured at 42 0C for 48 hours under microaerophilic atmosphere. Colonies were
enumerated and CFU per gram was calculated.

Microbiota transplantation and C. jejuni colonization
Cecal digesta samples from 28 day old birds infected with C. jejuni 81-176 and fed
1.5g/kg DCA diet were used for isolating microbiota and transplantation. The samples
were stored at -80 0C. The samples then cultured on BHI plates under aerobic or
anaerobic conditions for 48 hours at 42°C. The resulted bacteria were labelled as DCA
modulated aerobes (DCA-Aero) and DCA modulated Anaerobes (DCA-Anaero).
Chickens were orally gavaged once with 108 CFU/bird DCA-Aero or DCA-Anaero at 0
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days of age. At 10 days of age, the birds were infected with 109 CFU/bird chicken isolate
C. jejuni AR101. Cecal digesta collected at day 21 and 28 of age were serially diluted and
cultured for C. jejuni enumeration as described above.

In vitro C. jejuni growth with various bile acids
The impact of various species of bile acids on C. jejuni growth was measured. Briefly,
103 CFU/tube C. jejuni 81-176 were inoculated into 5 ml Campylobacter enrichment
broth in the presence of DCA, TCA, or AC at different concentrations of 0, 0.1, 1, 3, 5,
10 mM. The bacteria were cultured for 48 hours at 42 0C under microaerobic condition.
C. jejuni growth was then measured by OD600 on NanoDrop spectrophotometer
(Thermofisher).

Microbiota composition at phylum level
Cecal digesta samples were collected and DNA was extracted using bead beater
disruption and phenol: chloroform separation as describe before (Sun et al., 2018). The
levels of five phylum bacteria were determined using SYBR Green PCR Master mix
(Bio-Rad) on a Bio-Rad 384-well Real-Time PCR System. The PCR reactions were
performed according to the manufacturer’s recommendation. The following gene primers
(47, 49) were used: Universial 16S (Univ): 16s357F: 5’CTCCTACGGGGAGGCAGCAA-3’, 16s1392R: 5’-ACGGGCGGTGTGTRC-3’; αproteobacteria: α682F 5’-CIAGTGTAGAGGTGAAATT-3’, 908αR 5’CCCCGTCAATTCCTTTGAGTT-3’; γ-proteobacteria: 1080γF 5’TCGTCAGCTCGTGTYGTGA-3’ γ1202R 5’-CGTAAGGGCCATGATG-3’;
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Bacteroidetes (Bact): 798cfbF 5’-5’-CRAACAGGATTAGATACCCT-3’ cfb967R 5’GGTAAGGTTCCTCGCGTAT-3’; Firmicutes: 928F-Firm 5’TGAAACTYAAAGGAATTGACG-3’ 1040 Firm R 5’-ACCATGCACCACCTGTC-3’;
Actinobacteria: Act920F3 5’-TACGGCCGCAAGGCTA-3’ Act1200R 5’TCRTCCCCACCTTCCTCCG-3’. The relative fold change of each phylum in one
sample were normalized to Universal 16S gene using ΔCt method. For example, the
relative fold of bacteriodetes in one sample was calculated as 2(CtBact- CtUniv). The
percentage of each phylum was then calculated as the phylum relative fold divided by the
sum folds of all five phyla.

Statistical Analysis
Values are shown as mean ± standard error of the mean as indicated. Differences between
groups were analyzed using the nonparametric Mann–Whitney U test performed or
unpaired t-test with Welch’s correction using Prism 7.0 software. Experiments were
considered statistically significant if P values were <0.05.

2.4

Results

DCA prevents C. jejuni 81-176 cecal colonization in chickens
Secondary bile acid DCA prevents and treats C. jejuni-induced intestinal inflammation in
germ free Il10-/- mice (Sun et al., 2018). Because chickens are the natural reservoir of C.
jejuni, we then interrogate the hypothesis that DCA may modulate C. jejuni colonization
in chickens. The birds fed diet supplemented with 1.5 g/kg DCA were orally infected
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with a single dose of 109 CFU/bird human clinical isolate C. jejuni strain 81-176 at 14
days of age. C. jejuni colonization level was determined by collecting and culturing cecal
digasta of the birds at 16, 21, and 28 days of age using C. jejuni selective medium.
Notably, no C. jejuni in cecal disgesta was detected from birds without the bacterial
infection, suggesting the clean facility at our chicken farm and the success of strict
biosecurity measurement during our experiments. C. jejuni was readily colonized the
intestinal tract at a level of 105 CFU/g cecal digesta at 16 days of age, only 2 days post
infection (Figure 2.1). C. jejuni colonization level then increased more than 100 folds and
reached an almost plateau of 2.8 x107 CFU/g cecal digesta at 21 days of age. Remarkably,
DCA excluded C. jejuni cecal colonization at 100, 99.997, and 100% at 16, 21, and 28
days of age compared to the infected control birds, based on our detection limit of 102
CFU/g of the cecal digesta. These results suggest that the secondary bile acid DCA
effectively reduces C. jejuni 81-176 colonization in the intestinal tract of broiler chickens.

DCA promotes bird growth performance
Increased level of secondary bile acids DCA has been associated with obesity, but the
role of DCA on animal growth is unclear. To investigate the contribution of DCA on
chicken growth, the bird growth performance of body weight gain was measured at 14
and 28 days of age with or without C. jejuni infection. Unlike the outcome of severe
intestinal diseases when infecting to human or mice (14, 50), C. jejuni infection in
chickens neither induced diseases nor reduced the bird growth performance on body
weight gain compared to uninfected birds (Figure 2.2A). Remarkably, DCA promoted
growth performance of body weight gain by 36.3 % at 14 days of age, compared to
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control birds. The body weight gain of birds fed DCA diets posed 12.7% increase
compared to infected control birds at 28 days of age (Figure 2.2B). Interestingly, C. jejuni
colonization increased chicken body weight gain during d 14-28. These findings suggest
that DCA promotes bird growth performance of body weight gain and C. jejuni
colonization doesn’t induce adverse effect on bird health.

Bile acids fail to inhibit C. jejuni 81-176 in vitro growth
Since DCA prevented C. jejuni colonization in chickens, we then examine whether DCA
would directly inhibit C. jejuni growth. The bacterium was inoculated in Campylobacter
enrichment broth in the presence of different concentrations (0, 0.1, 1, 3, 5, 10 mM) of
bile acid DCA, CA and TCA and culture at 42°C for 48 hours under microaerobic
condition. Interestingly, DCA at 0.1, 1, and 5 mM didn’t alter C. jejuni growth, while
DCA at 3 and 10 mM increased C. jejuni growth by 4.7 and 4.5 folds, respectively
(Figure 2.3). Conjugated bile acid TCA and primary bile acid CA neither increased nor
reduced C. jejuni in vitro growth. Because bile acid DCA didn’t reduce but increased C.
jejuni growth, it is impossible that DCA against C. jejuni chicken colonization results
from direct inhibition of DCA on C. jejuni growth.

Bird ages of infection don’t alter C. jejuni AR101 chicken colonization
Our long-term goal is to use microbiome to reduced C. jejuni transmission in chickens
and to attenuated transmitted camplylobacteriosis using mouse model as reported before
(47, 50). Hence, C. jejuni colonized and transmitted in chickens with microbiome
treatment is required to be isolated for subsequently infecting Il10-/- mice. It was
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problematic when C. jejuni 81-176 couldn’t be isolated from DCA treated chickens as
showed in Figure 2.1. Different C. jejuni strains show variable colonization ability in
chickens (51) and chicken ages of infection impact C. jejuni chicken colonization (52).
Based on current state of knowledge, chickens were infected at 5, 10, and 14 days of age
with C. jejuni strain AR101 which was originally isolated from Poultry Health laboratory
at University of Arkansas at Fayetteville. As showed in Figure 2.4, C. jejuni AR101 was
able to colonize chicken ceca at 28 days of age. Interestingly, infecting AR101 at d 5, 10,
or 14 didn’t affect the bacterial chicken colonization (6.73x106, 2.4x107, or 7.49x106
CFU/g cecal digesta, respectively) (Figure 2.4). These data suggest that chicken ages of
infection don’t alter C. jejuni chicken colonization level. Based on these findings, in the
following experiments, birds were mostly infected with C. jejuni AR101 at day 10 of age
in order to have enough time for both C. jejuni colonization and microbiome
development.

Bile acids other than DCA don’t reduce C. jejuni AR101 colonization in chickens
Since DCA reduced C. jejuni 81-176 colonization in chickens, it is possible that other
bile acids also decrease the bacterial chicken colonization. To examine this hypothesis,
birds were gavaged with PBS or CA (1.5 g/kg body weight, daily) from 4 days of age and
then infected with C. jejuni AR101 once at 5 days of age. Interestingly, CA didn’t
significantly (1.82x106 vs. 6.73x106 CFU/g, P=0.1) reduce AR101 chicken colonization
(Figure 2.5) at day 28 of age, 23 days post infection. To assess if other secondary bile
acids attenuated C. jejuni chicken colonization, birds were fed diets supplemented with 0
or 1.5 g/kg DCA, LCA, or UDCA from d 0. The birds were infected once with C. jejuni
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AR101 at d10. Consistent with previous findings in Figure 2.1, DCA reduced C. jejuni
AR101 colonization compared to infected control birds (2.06x106 vs. 2.39x107 CFU/g),
while LCA and UDCA failed to decrease AR101 chicken colonization (2.05x107 and
1.40x107 CFU/g, respectively) (Figure 2.6). Together, these data suggest that only
secondary bile acid DCA effectively reduce C. jejuni chicken colonization.

DCA modulates bird cecal microbiota
Relative abundance of phylum Firmicutes is dramatically expanded from 54 to 93% in
intestine of rat fed primary bile acid CA (43). Since DCA neither inhibited C. jejuni in
vitro growth nor induced intestinal diseases (histopathology, data not shown) in chickens,
we then reasoned that DCA might modified microbiota against C. jejuni. To examine this
hypothesis, cecal digesta from birds infected with C. jejuni 81-176 and/or fed DCA
(Figure 2.1) were used to extract DNA. We selected these samples because C. jejuni
wasn’t detected in the samples and the samples would be used for following experiment
of isolating microbiota and transplantation. Phylum specific primers were used to analyze
the microbiota composition. Interestingly, C. jejuni infection didn’t change microbial
composition in microbiota of infected vs. uninfected birds (Figure 2.7). Remarkably,
DCA reduced the phylum Firmicutes (82.7 vs. 98.8%) compared to infected control birds,
while increased Bacteroidetes (16.9 vs. 0.8%). These results indicate that DCA is able to
alter the chicken gut microbiota.
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DCA modulated-anaerobes attenuates C. jejuni AR101 chicken colonization
Since DCA modulated chicken cecal microbiota, we then hypothesized that the altered
microbiota might contribute to the reduction of C. jejuni in chickens. In our previous
studies, we found that only anaerobes prevent C. jejuni-induced intestinal inflammation
in mice (47). Based on these knowledge, cecal digesta from birds fed DCA and infected
with C. jejuni 81-176 in Figure 2.1 were used to culture bacteria on BHI plates under
aerobic or anaerobic conditions. The resulting bacteria were labeled as DCA-modulated
aerobes (DCA-Aero) or DCA-modulated anaerobes (DCA-Anearo), respectively. To
functionally dissect the role of these newly isolated microbiota, birds were gavaged once
with DCA-Aero or DCA-Anaero microbiota at 0 day of age. The birds were then infected
with 109 CFU/bird C. jejuni AR101 at 10 days of age. Consistent with previous
observations, C. jejuni colonization in chicken ceca reached a plateau at a level of
2.80x107 CFU/g cecal digesta at 21 days of age (Figure 2.8), or 11 days post infection.
Importantly, DCA-Anaero significantly attenuated 93% of C. jejuni cecal colonization at
day 28 of age compared to infected control birds (1.79x106 vs.2.52x107 CFU/bird), while
DCA-Aero only reduced 34.46% of C. jejuni (1.65x107 vs. 2.52x107) colonization. These
findings suggest that DCA modulates microbiota and the modulation on anaerobes
mainly contributes to the reduction of C. jejuni colonization in chickens.

2.5

Discussion

Although C. jejuni is one of the prevalent foodborne pathogens in developed countries, a
paucity of information is available regarding reducing the pathogen in the main food
animal source of chickens. Moreover, the microbiota and cellular events implicated in
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host resistance/susceptibility to C. jejuni infection remain elusive (53, 54). Here we
report that microbial metabolic product DCA prevented colonization of both human
clinical isolate C. jejuni 81-176 and chicken isolate AR101 in chickens. Interestingly, bile
acids of DCA, CA, or TCA failed to reduce C. jejuni in vitro growth. Furthermore,
neither bird ages of C. jejuni infection at d 5, 10 or 14, nor other bile acids of CA, LCA
or UDCA influenced the bacterial chicken colonization levels. Mechanistic studies
revealed that DCA modified chicken cecal microbiota with increased phylum
Bacteroidetes and reduced Firmicutes. Importantly, DCA-modulated anaerobes prevented
C. jejuni chicken colonization. Altogether, these findings identified a novel mechanism
that DCA shapes microbiota composition against C. jejuni colonization in chickens,
suggesting a bidirectional interaction between microbiota and microbial metabolites.
A remarkable observation from our study is that DCA but not CA, LCA, or
UDCA prevents C. jejuni colonization in chickens. The logic reasoning would be that the
reduction would be through DCA directly impairing C. jejuni growth. DCA at 1.2 mM
inhibits C. jejuni 81-176 in vitro growth after 12 hour incubation (55), but Lin and
colleague found that the MICs of DCA and CA for C. jejuni 81-176 are 24 and 14 mM,
respectively (56). Interestingly, DCA at 48 mM fails to reduce C. jejuni 43431 growth at
6, 22, 25 and 30 hours of incubation but not at 16 hours (57). Consistent with the latter
reports, we found that conjugated bile acid TCA, primary bile acid CA, or secondary bile
acid DCA from 0.1 to 10 mM didn’t inhibit C. jejuni in vitro growth and DCA at high
concentrations even increased the bacterial growth. In animals, DCA reduces C. jejuni
induced intestinal inflammation in ex-Germ Free mice without altering C. jejuni
colonization level in colon (47). These knowledge and data suggest that DCA reduces C.
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jejuni colonization through mechanisms other than directly inhibiting the bacterial
growth.
Comprehensive database analysis showed that chicken microbiota at phylum level
is mainly comprised of 13 phyla including Firmicutes (70%), Bacteroidetes (12.3%),
Proteobacteria (9.3%) , and other small proportion of Actinobacteria, Cyanobacteria,
Spirochaetes, Synergisteles, Fusobacteria, Tenericutes, and Verrucomicrobia (58) (Wei et
al., 2013). Our phylum level analysis of microbiota has found that birds fed DCA were
colonized with reduced Firmicutes (82.7.1 vs. 98.8%) and increased Bacteroidetes (16.9
vs. 0.8%), which is associated with less C. jejuni colonization compared to control
infection birds. Notably, this finding is consistent with a field survey report that birds
from the farm with the highest Campylobacter counts are associated with the highest
percentage of Firmicutes and the lowest percentage of Bacteroidetes, although
microbiota composition is highly variable between inter- or intra-farms (59).
Interestingly, the microbiota in mice fed CA expands phylum Firmicutes (54 to 99%),
class Clostridia (70 to 39%), and genus Blautia (8.3 to 55-62%), in the expense of
phylum Bacteroidetes (30 to 0.39%) (43). The levels of bile acids are associated with
microbial community dynamics in the gut (40). Bile acids directly inhibit gut microbes
(41) and ileal bacterial overgrowth through FXR-induced antimicrobial peptides (42).
However, it remains elusive how various bile acid species differentially influence
intestinal microbiota composition.
Based on the results of DCA altering microbiota, we hypothesized that the
microbiota might play a role on protecting against C. jejuni chicken colonization. To
functionally dissect the protection of the DCA-modulated microbiota, microbiota culture
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and chicken microbiota transplant were performed. Indeed, DCA modulated anaerobes
reduced C. jejuni chicken colonization, while DCA modulated aerobes failed to do so.
Microbiota prevents against C. jejuni chicken colonization because C. jejuni colonizes at
higher level in germ free or antibiotics pre-treated chickens compared to conventional
birds (60). Specific members of microbiota play an important role against C. jejuni
induced diseases. Microbiota diversity and the relative abundances of genera Dorea and
Coprococcus in family Lachnospiraceae were higher in healthy travelers compared to
individuals with campylobacteriosis (54). Mouse microbiota with higher level of genera
Clostridium XI, Bifidobacterium, and Lactobacillus is associated with resistance to C.
jejuni induced colitis (47). The three genera bacteria metabolize conjugated bile acids
into secondary forms (29), which prevent campylobacteriosis in mice (47). Interestingly,
probiotics Bifidobacterium longum PCB133 failed to reduce C. jejuni chicken
colonization (61). We are processing the cecal samples to extract bacterial DNA to run
16S rDNA sequencing and we expect that we will find specific bacteria in DCAmodulated anaerobes responsible for protection against C. jejuni chicken colonization.
Finally, we found that C. jejuni colonization levels was independent on the ages
of birds infected. It remains controversial whether chicken ages of inflection play any
role on C. jejuni chicken colonization. C. jejuni is detected in 40% of broiler chicken
flocks at 4 weeks of age and in 90% of flocks at 7 weeks of age (62). This infection
pattern could be attributed to age-related resistance or the necessary timing for C. jejuni
transmission within house. Birds from parent breeders colonized with high level C. jejuni
strain 99/308 are resistant to 99/308 only at 8 days of age but not at 1 or 22 days of age
(63), suggesting specific and limited protection from the breeders. However, Han and
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colleagues showed that C. jejuni strains Lior6 and 0097 colonize less in birds of d 22
compared to d 1, after 14 days post infection (52). Because bird microbiota starts to
assemble after hatch, the older birds in some farms might develop microbiota resistant to
C. jejuni, as in Han and colleagues’ report (52). Similarly, germ free mice transferred to
SPF housing for 14 days resist against C. jejuni induced colitis (47). In those reports with
no age difference on C. jejuni colonization, the resistant microbiota assembly might be
blocked by strict biosecurity measurements or no available resistant microbiota in the
environment.
In conclusion, the microbiota metabolite secondary bile acid DCA decreases C.
jejuni counts and microbiota composition in the chicken intestine. At mechanistic level,
DCA-modulated anaerobic microbiota may be responsible for protecting against C. jejuni
colonization in chickens. These findings identified a novel mechanism that DCA shapes
microbiota composition against C. jejuni colonization in chickens, suggesting a
bidirectional interaction between microbiota and microbial metabolites. Simultaneously
reconstituting both microbiota and microbial metabolites may render better therapeutic
effect against enteritis or pathogen colonization.
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APPENDIX

Figure 2.1

DCA prevents against C. jejuni 81-176 colonization in chickens.

Cohorts of 13 one-day-old broiler chickens per group were fed 0 or 1.5 g/kg DCA diets.
The birds were infected with C. jejuni 81-176 at 14 days of age. Cecal digesta were
collected at 16, 21, and 28 days of age, serially diluted, and cultured on C. jejuni selective
medium at 42 ºC. C. jejuni was counted after 48 hours of culture. All graphs depict mean
± SEM. Significant if P<0.05.
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Figure 2.2

DCA promotes broiler chicken growth performance.

Birds were fed DCA diet and infected with C. jejuni as described in Figure 1. (A)
Periodic bird growth performance of body weight gain. (B) Accumulative body weight
gain at 28 days of age. All graphs depict mean ± SEM. Significant if P<0.05.
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Figure 2.3

Bile acids fail to inhibit C. jejuni in vitro growth.

C. jejuni 81-176 at 103 CFU was inoculated into 5 ml Campylobacter broth under
microaerophilic condition and cultured at 42 ºC for 48 hours. The broth was
supplemented with various concentrations (0, 0.1, 1, 3, 5, and 10 mM) of secondary bile
acid DCA, primary bile acid CA, or conjugated bile acid TCA.
Different letters represent significance (P<0.05) between treatments.
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Figure 2.4

Chicken ages of infection doesn’t influence the bacterial colonization
levels.

Cohorts of 18 one-day-old broiler chicks per group were fed basal diet and orally
gavaged with 109 CFU of C. jejuni AR 101 at 5, 10, or 14 days of age. At d 28, birds
were humanely sacrificed and cecal samples were collected. Cecal digesta samples were
serially diluted and cultured on Campylobacter selective media. Colonies were
enumerated and C. jejuni colonization levels were calculated. All graphs depict mean ±
SEM.
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Figure 2.5

CA fails to prevent C. jejuni colonization in chickens.

Cohorts of 18 one-day-old broiler chickens were orally gavaged daily with CA or PBS
from 4 days of age and infected with C. jejuni AR101 at d 5. All birds were sacrificed
and cecal digesta were collected at 28 days of age, serially diluted, and cultured on C.
jejuni selective medium at 42 ºC. C. jejuni was counted after 48 hours. All graphs depict
mean ± SEM. Significant if P<0.05.
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Figure 2.6

Other secondary bile acids fail to prevent C. jejuni colonization in
chickens.

Cohorts of 18 chicks per group were fed diets supplemented with 0 or 1.5 g/kg of DCA,
UDCA, or LCA. and were infected with C. jejuni AR 101 at day 10 of age. All birds were
sacrificed and cecal digesta were collected at 28 days of age, serially diluted, and cultured
on C. jejuni selective medium at 42 ºC. C. jejuni was counted after 48 hours. All graphs
depict mean ± SEM. Significant if P<0.05.

74

Figure 2.7

DCA modulates cecal microbiota.

Cohorts of 13 chicks per group were fed 0 or 1.5 g/kg DCA diets and infected with C.
jejuni 81-176 as described in Figure 1. Cecal digesta samples were collected and DNA
was isolated. Real time PCR was performed to calculate bacterial composition at phylum
level. All graphs depict mean ± SEM. *, P<0.05.
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Figure 2.8

DCA-modulated microbiota attenuates C. jejuni colonization in chickens.

Cohorts of 18 broiler chickens were orally transplanted with 108 CFU/bird DCA-Aero or
DCA-Anaero at d 0. The birds were then infected with 109 CFU/bird C. jejuni AR 101 at
10 days of age. Cecal digesta were collected at 21 and 28 days of age, serially diluted,
and cultured on C. jejuni selective medium at 42 ºC. C. jejuni was counted after 48 hours.
All graphs depict mean ± SEM. Significant if P<0.05.
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CONCLUSION
Campylobacter jejuni is one of the prevalent food borne pathogens inciting enteritis in
the developed countries. Poultry are the main reservoir of the pathogen, which infects
human through either direct contact with infected birds or consumption of undercooked
and contaminated chicken meat. Fecal microbiota transplantation of anaerobic microbiota
or supplementation of anaerobic metabolic product deoxycholic acid (DCA) is able to
prevent and treat C. jejuni-induced intestinal inflammation in ex-germ free Il10-/- mice.
Based on the knowledge, we hypothesized that DCA prevented C. jejuni chicken
colonization. We found that dietary DCA at 1.5 g/kg feed prevented C. jejuni human
clinical isolate 81-176 and chicken isolate AR101. Interestingly, bile acids of conjugated
primary bile acid taurocholic acid, deconjugated primary bile cholic acid (CA), and
secondary bile acid DCA failed to inhibit C. jejuni in vitro growth. Furthermore, CA and
other secondary bile acids lithocholic acid and urodeoxycholic acid didn’t reduce C.
jejuni AR101 chicken colonization. Analyzing microbiota at phylum level revealed that
DCA reduced the relative abundance of phylum Firmicutes but increased Bacteroidetes
compared to birds fed basal diet. Functionally examining the microbiota by
transplantation showed that DCA-modulated anaerobes reduced C. jejuni AR101 chicken
colonization compared to control birds. In conclusion, microbiota metabolic product
DCA attenuates C. jejuni colonization level in chickens through modulating bird
microbiota anaerobes. These findings may lay the ground work for exploring microbiota
and its metabolic activities to control C. jejuni or other pathogens.
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